Polygenic Score (PGS) ID: PGS001003

Predicted Trait
Reported Trait Number of medications taken
Mapped Trait(s) number of treatments or medications taken, self-reported (EFO_0009803)
Additional Trait Information https://biobankengine.stanford.edu/RIVAS_HG19/snpnet/INI137
Released in PGS Catalog: Oct. 21, 2021
Download Score FTP directory
Terms and Licenses
PGS obtained from the Catalog should be cited appropriately, and used in accordance with any licensing restrictions set by the authors. See EBI Terms of Use (https://www.ebi.ac.uk/about/terms-of-use/) for additional details.

Score Details

Score Construction
PGS Name GBE_INI137
Development Method
Name snpnet
Parameters NR
Variants
Original Genome Build GRCh37
Number of Variants 8,085
Effect Weight Type NR
PGS Source
PGS Catalog Publication (PGP) ID PGP000244
Citation (link to publication) Tanigawa Y et al. PLoS Genet (2022)
Ancestry Distribution
Score Development/Training
European: 100%
269,672 individuals (100%)
PGS Evaluation
European: 40%
African: 20%
East Asian: 20%
South Asian: 20%
5 Sample Sets

Development Samples

Score Development/Training
Study Identifiers Sample Numbers Sample Ancestry Cohort(s) Phenotype Definitions & Methods Age of Study Participants Participant Follow-up Time Additional Ancestry Description Additional Sample/Cohort Information
269,672 individuals European UKB white British ancestry

Performance Metrics

Disclaimer: The performance metrics are displayed as reported by the source studies. It is important to note that metrics are not necessarily comparable with each other. For example, metrics depend on the sample characteristics (described by the PGS Catalog Sample Set [PSS] ID), phenotyping, and statistical modelling. Please refer to the source publication for additional guidance on performance.

PGS Performance
Metric ID (PPM)
PGS Sample Set ID
(PSS)
Performance Source Trait PGS Effect Sizes
(per SD change)
Classification Metrics Other Metrics Covariates Included in the Model PGS Performance:
Other Relevant Information
PPM007778 PSS004836|
African Ancestry|
6,483 individuals
PGP000244 |
Tanigawa Y et al. PLoS Genet (2022)
Reported Trait: # of medications taken : 0.10873 [0.09444, 0.12301]
Incremental R2 (full-covars): -0.00564
PGS R2 (no covariates): 0.00035 [-0.00056, 0.00126]
age, sex, UKB array type, Genotype PCs
PPM007779 PSS004837|
East Asian Ancestry|
1,702 individuals
PGP000244 |
Tanigawa Y et al. PLoS Genet (2022)
Reported Trait: # of medications taken : 0.10438 [0.07695, 0.1318]
Incremental R2 (full-covars): -0.01455
PGS R2 (no covariates): 3e-05 [-0.00047, 0.00053]
age, sex, UKB array type, Genotype PCs
PPM007780 PSS004838|
European Ancestry|
24,894 individuals
PGP000244 |
Tanigawa Y et al. PLoS Genet (2022)
Reported Trait: # of medications taken : 0.09752 [0.09052, 0.10452]
Incremental R2 (full-covars): 0.01417
PGS R2 (no covariates): 0.01416 [0.01125, 0.01708]
age, sex, UKB array type, Genotype PCs
PPM007781 PSS004839|
South Asian Ancestry|
7,812 individuals
PGP000244 |
Tanigawa Y et al. PLoS Genet (2022)
Reported Trait: # of medications taken : 0.13684 [0.1227, 0.15098]
Incremental R2 (full-covars): 0.00757
PGS R2 (no covariates): 0.00724 [0.0035, 0.01098]
age, sex, UKB array type, Genotype PCs
PPM007782 PSS004840|
European Ancestry|
67,419 individuals
PGP000244 |
Tanigawa Y et al. PLoS Genet (2022)
Reported Trait: # of medications taken : 0.08553 [0.0815, 0.08957]
Incremental R2 (full-covars): 0.01548
PGS R2 (no covariates): 0.01558 [0.01372, 0.01743]
age, sex, UKB array type, Genotype PCs

Evaluated Samples

PGS Sample Set ID
(PSS)
Phenotype Definitions and Methods Participant Follow-up Time Sample Numbers Age of Study Participants Sample Ancestry Additional Ancestry Description Cohort(s) Additional Sample/Cohort Information
PSS004836 6,483 individuals African unspecified UKB
PSS004837 1,702 individuals East Asian UKB
PSS004838 24,894 individuals European non-white British ancestry UKB
PSS004839 7,812 individuals South Asian UKB
PSS004840 67,419 individuals European white British ancestry UKB Testing cohort (heldout set)